Evidence map›Paper›PMID 29535414›Full record

ArticleThe American journal of gastroenterology2018

Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen: data from the PRECISION trial.

Neville D Yeomans, David Y Graham, Qiuqing Wang, Kathy Wolski, Jeffrey Borer, Elaine M Husni, Peter Libby, Michael A Lincoff, Thomas Lüscher, Lisa M Wisniewski and 3 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The American journal of gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Neville D YeomansUniversity of Melbourne Department of Medicine, Austin Health, Melbourne, Victoria, and Western Sydney University, Campbelltown, NSW, Australia. Baylor College of Medicine, Veterans Affairs Medical Center, Houston, TX, USA. Cleveland Clinic, Cleveland, OH, USA. Downstate College of Medicine, State University of New York, New York, NY, USA. Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Royal Brompton and Harefield Hospital Trust and Imperial College, London, United Kingdom. Pfizer, New York, NY, USA. Pfizer Ltd, Tadworth, UK.
David Y GrahamUniversity of Melbourne Department of Medicine, Austin Health, Melbourne, Victoria, and Western Sydney University, Campbelltown, NSW, Australia. Baylor College of Medicine, Veterans Affairs Medical Center, Houston, TX, USA. Cleveland Clinic, Cleveland, OH, USA. Downstate College of Medicine, State University of New York, New York, NY, USA. Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Royal Brompton and Harefield Hospital Trust and Imperial College, London, United Kingdom. Pfizer, New York, NY, USA. Pfizer Ltd, Tadworth, UK.
Qiuqing WangUniversity of Melbourne Department of Medicine, Austin Health, Melbourne, Victoria, and Western Sydney University, Campbelltown, NSW, Australia. Baylor College of Medicine, Veterans Affairs Medical Center, Houston, TX, USA. Cleveland Clinic, Cleveland, OH, USA. Downstate College of Medicine, State University of New York, New York, NY, USA. Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Royal Brompton and Harefield Hospital Trust and Imperial College, London, United Kingdom. Pfizer, New York, NY, USA. Pfizer Ltd, Tadworth, UK.
Kathy WolskiUniversity of Melbourne Department of Medicine, Austin Health, Melbourne, Victoria, and Western Sydney University, Campbelltown, NSW, Australia. Baylor College of Medicine, Veterans Affairs Medical Center, Houston, TX, USA. Cleveland Clinic, Cleveland, OH, USA. Downstate College of Medicine, State University of New York, New York, NY, USA. Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Royal Brompton and Harefield Hospital Trust and Imperial College, London, United Kingdom. Pfizer, New York, NY, USA. Pfizer Ltd, Tadworth, UK.
Jeffrey BorerUniversity of Melbourne Department of Medicine, Austin Health, Melbourne, Victoria, and Western Sydney University, Campbelltown, NSW, Australia. Baylor College of Medicine, Veterans Affairs Medical Center, Houston, TX, USA. Cleveland Clinic, Cleveland, OH, USA. Downstate College of Medicine, State University of New York, New York, NY, USA. Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Royal Brompton and Harefield Hospital Trust and Imperial College, London, United Kingdom. Pfizer, New York, NY, USA. Pfizer Ltd, Tadworth, UK.
Elaine M HusniUniversity of Melbourne Department of Medicine, Austin Health, Melbourne, Victoria, and Western Sydney University, Campbelltown, NSW, Australia. Baylor College of Medicine, Veterans Affairs Medical Center, Houston, TX, USA. Cleveland Clinic, Cleveland, OH, USA. Downstate College of Medicine, State University of New York, New York, NY, USA. Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Royal Brompton and Harefield Hospital Trust and Imperial College, London, United Kingdom. Pfizer, New York, NY, USA. Pfizer Ltd, Tadworth, UK.
Peter LibbyUniversity of Melbourne Department of Medicine, Austin Health, Melbourne, Victoria, and Western Sydney University, Campbelltown, NSW, Australia. Baylor College of Medicine, Veterans Affairs Medical Center, Houston, TX, USA. Cleveland Clinic, Cleveland, OH, USA. Downstate College of Medicine, State University of New York, New York, NY, USA. Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Royal Brompton and Harefield Hospital Trust and Imperial College, London, United Kingdom. Pfizer, New York, NY, USA. Pfizer Ltd, Tadworth, UK.
Michael A LincoffUniversity of Melbourne Department of Medicine, Austin Health, Melbourne, Victoria, and Western Sydney University, Campbelltown, NSW, Australia. Baylor College of Medicine, Veterans Affairs Medical Center, Houston, TX, USA. Cleveland Clinic, Cleveland, OH, USA. Downstate College of Medicine, State University of New York, New York, NY, USA. Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Royal Brompton and Harefield Hospital Trust and Imperial College, London, United Kingdom. Pfizer, New York, NY, USA. Pfizer Ltd, Tadworth, UK.
Thomas LüscherUniversity of Melbourne Department of Medicine, Austin Health, Melbourne, Victoria, and Western Sydney University, Campbelltown, NSW, Australia. Baylor College of Medicine, Veterans Affairs Medical Center, Houston, TX, USA. Cleveland Clinic, Cleveland, OH, USA. Downstate College of Medicine, State University of New York, New York, NY, USA. Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Royal Brompton and Harefield Hospital Trust and Imperial College, London, United Kingdom. Pfizer, New York, NY, USA. Pfizer Ltd, Tadworth, UK.
Lisa M WisniewskiUniversity of Melbourne Department of Medicine, Austin Health, Melbourne, Victoria, and Western Sydney University, Campbelltown, NSW, Australia. Baylor College of Medicine, Veterans Affairs Medical Center, Houston, TX, USA. Cleveland Clinic, Cleveland, OH, USA. Downstate College of Medicine, State University of New York, New York, NY, USA. Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Royal Brompton and Harefield Hospital Trust and Imperial College, London, United Kingdom. Pfizer, New York, NY, USA. Pfizer Ltd, Tadworth, UK.
Warren BaoUniversity of Melbourne Department of Medicine, Austin Health, Melbourne, Victoria, and Western Sydney University, Campbelltown, NSW, Australia. Baylor College of Medicine, Veterans Affairs Medical Center, Houston, TX, USA. Cleveland Clinic, Cleveland, OH, USA. Downstate College of Medicine, State University of New York, New York, NY, USA. Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Royal Brompton and Harefield Hospital Trust and Imperial College, London, United Kingdom. Pfizer, New York, NY, USA. Pfizer Ltd, Tadworth, UK.
Chris WalkerUniversity of Melbourne Department of Medicine, Austin Health, Melbourne, Victoria, and Western Sydney University, Campbelltown, NSW, Australia. Baylor College of Medicine, Veterans Affairs Medical Center, Houston, TX, USA. Cleveland Clinic, Cleveland, OH, USA. Downstate College of Medicine, State University of New York, New York, NY, USA. Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Royal Brompton and Harefield Hospital Trust and Imperial College, London, United Kingdom. Pfizer, New York, NY, USA. Pfizer Ltd, Tadworth, UK.
Steven E NissenUniversity of Melbourne Department of Medicine, Austin Health, Melbourne, Victoria, and Western Sydney University, Campbelltown, NSW, Australia. Baylor College of Medicine, Veterans Affairs Medical Center, Houston, TX, USA. Cleveland Clinic, Cleveland, OH, USA. Downstate College of Medicine, State University of New York, New York, NY, USA. Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Royal Brompton and Harefield Hospital Trust and Imperial College, London, United Kingdom. Pfizer, New York, NY, USA. Pfizer Ltd, Tadworth, UK.

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
NIDDK NIH HHS P30 DK056338
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NaproxenPancreatitisAnti-Inflammatory Agents, Non-SteroidalCase-Control StudiesCelecoxibHumansIbuprofenRiskTaiwanAnti-Inflammatory Agents, Non-SteroidalCelecoxibIbuprofenNaproxen

Identifiers

PMID29535414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.